Avandia Lawsuits continue to be filed by diabetes patients who suffered heart attack, stroke or congestive heart failure (CHF) after taking the drug Avandia (Rosiglitazone) for type 2 diabetes.
Drug lawsuit attorneys continue file cases on behalf of the loved ones of diabetics who suffered cardiovascular death after taking Avandia. Lawsuit settlements in 2010 have been won on claims that heart problems and cardiovascular death were caused by Avandia.
Data from dozens of Avandia trials involving tens of thousands of diabetes patients has been reviewed and analyzed. Scientists conclude that Avandia use increases heart attack risk.
Lawsuits against Avandia drug manufacturer GlaxoSmithKline claim that the drug company knew about the medication’s increased heart attack risks for many years, but concealed the information from diabetes patients, doctors and the FDA.
On September 23, 2010, in response to growing evidence of the elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia, the FDA significantly restricted use of the diabetes drug.
The attorneys at AvandiaRecallNews.com no longer are accepting new Avandia cases.